Displaying 76–100 of 11035 results for

Sort By Relevance Sort By Date
1... 2 3 4 5 6 ...442

Potential buyers eye Novartis site as layoffs loom

(News)

At least six companies have toured a Novartis manufacturing facility that’s up for grabs in England.

Vertex snaps up company working on cure for Type 1 diabetes

(News)

Vertex Pharmaceuticals announced this week that it is buying Semma Therapeutics for $950 million in cash.

AstraZeneca shares hit all-time high after clinical trial

(News)

Positive results from a trial looking into the cardiovascular benefits of a diabetes drug have sent AstraZeneca shares flying to record highs.

Bayer hires former J&J exec to manage pharma deals

(News)

Bayer has hired Marianne De Backer to oversee the German drugmaker’s pharma acquisitions.

Novartis licenses multiple sclerosis biosim

(News)

The company's Sandoz unit has licensed a version of natalizumab from Polpharma Biologics.

Roche and Spark extend takeover yet again

(News)

The latest delay cites giving additional time to the FTC and the CMA to review the acquisition

Current Issue

Most current issue of pharmaceutical manufacturing magazine

Current Issue

Most current issue of pharmaceutical manufacturing magazine

September 2019

Pharma in review: trending stories 8/30/19

(News)

pharma manufacturing news in review

Sun Pharma cleared in whistleblower allegation

(News)

A preliminary probe by the Securities and Exchange Board of India (SEBI) has has cleared Sun Pharma of a fraud alleged by a whistleblower.

Kids develop “werewolf syndrome” after being given mislabeled medicine

(News)

At least 17 children in Spain developed a form of “werewolf syndrome” after they were given mislabeled medication.

FDA widens generic drug recall probe beyond heart meds

(News)

The FDA is reportedly expanding its investigation related into impurities found in a class of blood pressure medications.

Report: Purdue looking to reach massive opioid settlement

(News)

With about 2,000 opioid-related lawsuits looming around the country, Purdue Pharma is reportedly offering to settle for $10-12 billion.

Oklahoma judge rules against J&J in landmark trial

(News)

A judge in Oklahoma has ordered Johnson & Johnson to pay $572 million in damages for its role in the opioid epidemic.

Blockbuster-bound Lilly drug wins another FDA nod

(News)

Eli Lilly’s Taltz has been given the go-ahead for a new indication, which could help propel the drug to blockbuster status.

Boehringer pharma head to step down

(News)

Allan Hillgrove, the board member responsible for the company's human pharma and biopharma business, is set to retire at the end of the year as the rest of the Boehringer Ingelheim board is getting shaken up..

FDA fast tracks AstraZeneca diabetes drug

(News)

Farxiga is being given a speedy review as a method to prevent heart and kidney failure in patients with chronic kidney disease.

Amgen to buy Celgene’s Otezla for $13.4B

(News)

Amgen has agreed to buy Celgene’s psoriasis treatment for $13.4 billion in cash, in a deal that will pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene.

FibroGen CEO passes away unexpectedly

(News)

Pfizer gets priority review for cancer drug label expansion

(News)

Pfizer and partner Astellas announced that the FDA has accepted the supplemental New Drug Application looking for label expansion of cancer drug, Xtandi and granted priority review designation.

Pharma in review: trending stories 8/23/19

(News)

pharma manufacturing news in review

New tuberculosis vax could improve protection

(News)

Australian researchers from the Centenary Institute and the University of Sydney have successfully developed and tested a new type of vaccine targeting tuberculosis.

BIO 2019: It starts with one

(Article)

BIO 2019 shows how incremental investments make a global impact

Today's solid dose drugs: High potency, high stakes

(Article)

Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms

Sort By Relevance Sort By Date
1... 2 3 4 5 6 ...442